AI & Machine Learning Startups
32,342 companies tagged AI & Machine Learning, with their investors and founders.
Oliver builds technology for the pet commerce ecosystem, using algorithms that analyze pet parent and animal data to power product recommendations, subscriptions and deliveries. It offers tools such as real-time stock, dynamic pricing, clinical integration, shared fulfillment and behavioral intelligence for pet parents, veterinarians and pet shops.
1 investor
Olivo Sciences licenses de-identified multimodal patient data (multi-omics, imaging, clinical, and wearable) and provides domain-trained AI models for biopharma companies across the drug development cycle, with a focus on brain and neurological disorders. It supports target discovery, clinical trial design and enrollment, and post-marketing real-world evidence generation.
1 investor
Ollie is an AI assistant for families that helps manage household logistics, meal planning, and daily coordination through text-based interactions. The service aims to reduce the mental load of family life by organizing information and keeping families on top of their responsibilities.
1 investor
Omaiven built AI-powered automation and a "digital workforce" to handle administrative healthcare operations such as scheduling, patient access, and reducing missed appointments, working alongside existing systems used by healthcare organizations and clinics. The company operated from 2018 until concluding operations in 2025.
1 investor
Ombud offers AI-enabled, context-aware assistants ("Ombuddies") that automate sales engineering and response management tasks such as RFPs, SOWs, POCs, and proposals. It targets enterprise-level Revenue Operations (RevOps) teams to reduce manual work and lower sales-related costs.
1 investor
Omega Healthcare provides AI-powered automation and managed services for healthcare organizations, covering revenue cycle management, health data curation, payer operations, and drug access and affordability. It offers modular to fully managed solutions aimed at strengthening revenue operations, care coordination, and clinical data workflows.
1 investor
Omelas develops Atreus, an agentic AI workbench that synthesizes multilingual and multidomain intelligence from siloed datasets to generate reports and presentations for analysts. The platform is deployed with US government agencies and geopolitical risk firms.
1 investor
OMG Digital builds digital media brands and a content discovery platform aimed at African audiences. Its media properties include OMGVoice and Bitnode.
1 investor
Omi builds "Digital Twins" — accurate digital replicas of physical consumer products — and uses them to generate product visuals such as PDPs, retailer assets, campaign, lifestyle and AI-ready content for every SKU and market. It serves consumer brands managing large product catalogs across multiple channels and localized markets.
1 investor
Omica develops precision oncology technology focused on the Latin American market, serving life sciences organizations and cancer centers.
1 investor
OmicsBank positions itself around phenotyped patient cohorts and omics data used to validate novel drug targets and stratify responders ahead of clinical trials. It references AI-discovered drug targets and biomarker analysis in the context of biotech drug development.
1 investor
Omidyar Network is a philanthropic organization that invests in and collaborates with ventures and organizations working to guide the digital revolution toward shared power, prosperity, and possibility. The organization operates across multiple sectors and industries through a dual-checkbook structure supporting both nonprofits and businesses.
1 investor
OMIQ offers flow cytometry data analysis software, including AdaptiGate, a machine-learning autogating tool that adapts user-defined gates from a template file across all samples in a dataset. It serves researchers and organizations performing flow cytometry analysis in the life sciences.
1 investor
Omlet offers a composable observability stack that ingests metrics, logs, and traces via OpenTelemetry and provides plug-in dashboards, serverless automation, custom visualizations, and an AI agent. It targets engineering and operations teams looking to unify infrastructure signals into a single platform with features like drag-and-drop dashboards, in-browser query/visualization code blocks, and role-based access control.
1 investor
Singulier is an AI and digital advisory consultancy that partners with private equity funds and their portfolio companies to deliver AI due diligence, data foundations, and AI-driven transformation. It focuses on the Finance, Business Services, Software & Tech, and Consumer sectors across Europe.
1 investor
OmniChat is an AI-powered conversational platform designed to help businesses integrate marketing, sales, and customer relationship management on WhatsApp. It enables companies to automate customer interactions and drive conversions through AI-driven messaging experiences.
1 investor
Omni AI is an AI-powered practice management and revenue cycle management platform for specialty physician practices, using AI agents to automate front-end administrative work such as benefit verification and prior authorization. It integrates with a practice's EMR, practice management, and clearinghouse systems, including custom connections to local HMO plans, to reduce claim denials and improve collections.
1 investor
Omnia helps agencies track AI visibility by monitoring AI model prompts and citations across geographies, delivering benchmarking and client reporting as a managed service. The platform enables agencies to standardize AI visibility tracking into a repeatable offering that clients can renew.
1 investor
Omnia Family Wealth is a registered investment advisor that manages portfolios for clients, with a current focus on assessing and integrating artificial intelligence exposures across asset classes including private equity, venture capital, public equities, credit, and real assets. The firm conducts research on how AI and technological shifts are reshaping business models and competitive dynamics to inform investment decisions.
1 investor
OmniAb develops transgenic animal platforms engineered to generate human antibodies for therapeutic drug discovery, serving biopharmaceutical researchers and drug developers.
1 investor
OmniBio develops biologically-inspired AI models for autonomous robots and machines used in manufacturing, agriculture, and construction. The technology enables robots to learn and adapt in dynamic environments without traditional sensors or connectivity.
1 investor
Omnibound helps marketing teams optimize their presence in AI search results by capturing buyer questions and mapping content across decision-making stakeholders. The platform connects AI search visibility to pipeline outcomes for enterprise marketing teams.
1 investor
OmniBuds develops ear-worn biosensing earbuds that continuously monitor cardiovascular and physiological signals through AI-powered analysis. The platform serves researchers, clinicians, and health-conscious individuals seeking accessible, unobtrusive insight into their body's cardiovascular responses during daily life.
1 investor
Omnic.AI provides AI-powered esports player performance analytics and coaching through its Omnic Forge platform, which analyzes gameplay video to deliver customized training recommendations. The platform serves amateur and professional esports players seeking to improve their competitive performance through data-driven insights.
1 investor









